These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4545491)

  • 1. [Characteristics of blast transformation of lymphocytes and certain problems of pathogenesis of lymphogranulomatosis].
    Martynov SM; Loginskiĭ VE; Polishchuk RS
    Probl Gematol Pereliv Krovi; 1974 Mar; 19(3):24-8. PubMed ID: 4545491
    [No Abstract]   [Full Text] [Related]  

  • 2. The pathogenesis of Hodgkin's disease.
    Stuart AE
    J Pathol; 1978 Dec; 126(4):239-54. PubMed ID: 372510
    [No Abstract]   [Full Text] [Related]  

  • 3. [T- and B-lymphocytes in lymphogranulomatosis].
    Il'in NV; Letskiĭ VB; Vinokurova NA
    Vopr Onkol; 1977; 23(6):9-15. PubMed ID: 303412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunolical aspects of diagnosis and pathogenesis of lymphogranulomatosis].
    Iarilin AA
    Med Radiol (Mosk); 1976 Oct; 21(10):18-22. PubMed ID: 799739
    [No Abstract]   [Full Text] [Related]  

  • 5. [Various immunomorphological tests of cellular immunity in lymphogranulomatosis].
    Gelenko AM
    Arkh Patol; 1979; 41(1):18-21. PubMed ID: 106807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blastogenic transformation of lymphocytes following phytohaemagglutinin treatment in vitro in malignant lymphomas. I. Hodgkin's disease. (Correlation with immunity response of the cellular type and with the clinical status).
    Libánský J; Lukásová M; Pinosová I
    Neoplasma; 1973; 20(1):51-60. PubMed ID: 4702205
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cellular immunity indices in lymphogranulomatosis].
    Baĭsogolov GD; Pavlov VV; Konopliannikov AG; Kozlov VM; Kulish IuS
    Sov Med; 1981; (6):29-34. PubMed ID: 6974405
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunologic phenomena in lymphogranulomatosis: key to etiology and pathogenesis?].
    Gallmeier WM
    Hamatol Bluttransfus; 1976; 18():81-7. PubMed ID: 786812
    [No Abstract]   [Full Text] [Related]  

  • 9. [Etiology and pathogenesis of lymphogranulomatosis].
    Lushnikov EF; Kir'ianov NA
    Sov Med; 1986; (4):57-62. PubMed ID: 3012796
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunological characteristics of the peripheral blood and lymph node lymphocytes in Hodgkin's disease and reactive lymphadenitis].
    Loginskiĭ VE; Polishchuk RS; Logoĭda DM
    Probl Gematol Pereliv Krovi; 1980 Nov; 25(11):35-8. PubMed ID: 6969399
    [No Abstract]   [Full Text] [Related]  

  • 11. [Blast transformation of lymphocytes in lymphogranulomatosis].
    Simbirtseva GD; Petrasheva NI
    Klin Med (Mosk); 1974 Mar; 52(3):124-8. PubMed ID: 4466933
    [No Abstract]   [Full Text] [Related]  

  • 12. [Capacity of lymphocytes from persons with lymphogranulomatosis for blast transformation in vitro under the effect of phytohemagglutin].
    Slavnaia IL; Kaiumova MG
    Lab Delo; 1972; 4():208-12. PubMed ID: 4119837
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunological aspects of lymphogranulomatosis].
    Blokhina NG; Agafonov VA; Bykovskaia SN; Naumova ER; Raushenbakh MO
    Ter Arkh; 1984; 56(10):125-30. PubMed ID: 6098042
    [No Abstract]   [Full Text] [Related]  

  • 14. [Current views on the mechanism of immunological disorders in Hodgkin's disease].
    Voĭtenkov BO; Letskiĭ VB; Gavrilenkova LP
    Eksp Onkol; 1984; 6(4):17-22. PubMed ID: 6389087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lymphogranulomatosis and the thymus].
    Vasil ev VN
    Vopr Onkol; 1980; 26(7):87-95. PubMed ID: 6996322
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunological data in the clinical evaluation of Hodgkin's diseases].
    Burchardt K
    Z Gesamte Inn Med; 1981 Nov; 36(21):840. PubMed ID: 6977241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical analysis of the distribution of lymphocyte subpopulations in Hodgkin's disease.
    Borowitz MJ; Croker BP; Metzgar RS
    Cancer Treat Rep; 1982 Apr; 66(4):667-74. PubMed ID: 6210433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunity and hypersensitivity in Hodgkin's lymphoma].
    Leoni P; Marchegiani G; Montillo M; Centurioni R; Montroni M; Danieli G
    Minerva Med; 1982 May; 73(20):1361-9. PubMed ID: 6210855
    [No Abstract]   [Full Text] [Related]  

  • 19. [Concentration of rosette-forming cells and functional activity of peripheral blood T-lymphocytes in patients with different stages of lymphogranulomatosis].
    Loseva MI; Fridliand DIu
    Ter Arkh; 1981; 53(9):68-71. PubMed ID: 6975503
    [No Abstract]   [Full Text] [Related]  

  • 20. The activation profile of tumour-associated reactive T-cells differs in the nodular and diffuse patterns of lymphocyte predominant Hodgkin's disease.
    Lin P; Medeiros LJ; Wilder RB; Abruzzo LV; Manning JT; Jones D
    Histopathology; 2004 Jun; 44(6):561-9. PubMed ID: 15186271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.